Cite
HARVARD Citation
Hramiak, I. et al. (2022). Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial. Diabetes, obesity & metabolism. 24 (10), pp. 1998-2007. [Online].